Tag: monkeypox

  • Scientists at U.S. Government Lab Charged With Smuggling Deactivated Mpox Virus Into America

    Scientists at U.S. Government Lab Charged With Smuggling Deactivated Mpox Virus Into America

    Two scientists employed at a U.S. government research laboratory have been charged with smuggling deactivated mpox virus samples into the United States from Africa and allegedly making false statements to federal authorities during an airport inspection.

    Federal prosecutors unsealed a criminal complaint Tuesday against Vincent Munster, chief of the Virus Ecology Section at Rocky Mountain Laboratories in Hamilton, Montana, and his colleague Claude Kwe.

    Authorities allege the two researchers attempted to bring vials containing deactivated mpox virus into the United States without declaring them or obtaining the required authorization.

    Airport Inspection Leads to Investigation

    According to court documents, Munster and Kwe were stopped by customs officials at Detroit Metropolitan Airport in January after returning from a nine-day trip to the Republic of the Congo via Paris.

    Investigators said Munster denied carrying biological materials or scientific samples into the country. However, subsequent testing allegedly revealed that the scientists possessed vials containing inactivated mpox virus.

    The FBI claims the samples were not declared to customs officials and that the researchers lacked the necessary permits required for transporting biological materials across international borders.

    Authorities further allege that Munster falsely assured investigators that any required documentation was stored on his laptop, reportedly telling officers, “I do this all the time.”

    Federal investigators contend those statements were materially false.

    Public Health and Security Concerns

    The case has attracted significant attention because it involves researchers working within the U.S. government’s public health system.

    Marcus Sykes of the Department of Health and Human Services Office of Inspector General said that deliberately concealing biological materials from customs authorities represents a serious breach of public trust and could potentially create public health risks.

    Officials have emphasized that the charges relate to alleged violations of importation and reporting requirements rather than accusations that the virus itself was active or capable of causing infection.

    The samples involved were reportedly deactivated, meaning the virus had been rendered noninfectious.

    Researchers With Extensive Mpox Experience

    Court filings indicate both scientists have extensive backgrounds studying mpox and other emerging infectious diseases.

    Authorities did not specify why the researchers allegedly attempted to transport the samples without authorization, nor did court documents explain what research purpose the materials may have served.

    Munster and Kwe are scheduled to appear in federal court in Missoula, Montana.

    Understanding Mpox

    Mpox, formerly known as monkeypox, is a viral disease caused by the mpox virus. Common symptoms include fever, swollen lymph nodes, fatigue, and a distinctive rash. While most patients recover fully, severe illness can occur in some cases.

    The virus was first identified in 1958 during outbreaks among research monkeys, though it primarily circulates among animals and humans in parts of Central and West Africa.

    Global awareness of mpox increased dramatically in 2022 when outbreaks spread across more than 70 countries. Researchers confirmed that person-to-person transmission could occur through close physical contact, including sexual contact.

    The recent outbreak in the Democratic Republic of the Congo led to thousands of deaths before health authorities declared the two-year outbreak over in April 2026.

  • Manitoba Confirms Canada’s First Case of New Mpox Strain, Clade Ib

    Manitoba Confirms Canada’s First Case of New Mpox Strain, Clade Ib

    Manitoba has reported Canada’s first confirmed case of the newly identified clade Ib strain of mpox, previously known as monkeypox. The Public Health Agency of Canada (PHAC) confirmed this development on Friday, marking a significant milestone in the country’s public health monitoring.

    What is Clade Ib Mpox?

    Mpox viruses are categorized into two primary clades: clade I and clade II. Clade I, which includes the Ib sublineage, is considered more severe and historically associated with higher mortality rates. Unlike clade II, responsible for the global outbreak in 2022 characterized by milder symptoms and transmission via sexual contact, clade I has traditionally been linked to zoonotic infections in rural regions of the Congo.

    However, research conducted earlier this year by a Canadian-Congolese team identified clade Ib as a lineage capable of efficient human-to-human transmission. This strain has primarily affected vulnerable populations, including sex workers, in central and eastern Africa.

    Details of the Manitoba Case

    The Manitoba case is linked to travel and associated with an ongoing clade I mpox outbreak in Africa. The individual developed symptoms shortly after returning to Canada and is now isolating. A sample analyzed by Winnipeg’s National Microbiology Laboratory confirmed the clade Ib diagnosis.

    The province has stated it will not release further identifying information to protect the individual’s privacy. Public health officials are conducting contact tracing as part of their investigation.

    Public Health Risk and Transmission

    The overall risk to the general public remains low, according to Manitoba’s health authorities. Mpox is primarily transmitted through close personal contact, including sexual contact or exposure to contaminated materials like bedding or towels. Both clades of the virus can spread in this manner.

    While mpox symptoms are often mild—characterized by pox-like lesions, fever, and swollen lymph nodes—severe cases can occur, particularly with clade I strains. The province emphasized the importance of seeking medical attention if symptoms arise, especially after travel to regions experiencing mpox outbreaks.

    A Broader Global Context

    The emergence of clade Ib in Canada reflects a growing trend of travel-associated cases globally. Similar infections have recently been reported in the United States, underscoring the need for vigilance in monitoring international outbreaks.

    Health Canada advises the public to stay informed about mpox risks, particularly for those traveling to affected regions. Preventative measures such as avoiding close contact with symptomatic individuals and maintaining hygiene around potentially contaminated items remain key.

    For more information on mpox and its symptoms, visit Health Canada’s website.

    Source : Swifteradio.com